Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$133.04
neg -1.13
-0.84%
Today's Range: 133.03 - 134.74 | JNJ Avg Daily Volume: 5,582,600
Last Update: 08/17/17 - 4:00 PM EDT
Volume: 5,528,397
YTD Performance: 15.77%
Open: $134.16
Previous Close: $134.17
52 Week Range: $109.32 - $137.08
Oustanding Shares: 2,683,999,728
Market Cap: 357,991,883,721
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 7 7 7 8
Moderate Sell 0 0 0 0
Strong Sell 2 0 0 0
Mean Rec. 2.35 2.00 2.00 2.06
Latest Dividend: 0.84
Latest Dividend Yield: 2.52%
Dividend Ex-Date: 08/25/17
Price Earnings Ratio: 22.42
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
22.42 22.50 36.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.03% 11.50% 31.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.60 0.00 0.00
Net Income 7.30 0.20 0.06
EPS 8.20 0.20 0.07
Earnings for JNJ:
EBITDA 24.92B
Revenue 71.89B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.79 $1.74 $7.18 $7.72
Number of Analysts 10 8 11 12
High Estimate $1.84 $1.81 $7.22 $7.90
Low Estimate $1.75 $1.68 $7.14 $7.52
Prior Year $1.68 $1.58 $6.73 $7.18
Growth Rate (Year over Year) 6.49% 10.05% 6.75% 7.45%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Hear me out: The same lessons and disciplines are useful in both.

Don't Get Out of Joint Real Money Pro($)

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
The dollar index is now in an area of strong support.
The word of the day is "rotation." No "thanks a latte" for me -- I'm staying with my core short of Starbucks (SBUX) . But buy Hartford Insurance Group (HIG

Here's What Up (and Down) Real Money Pro($)

After 90 minutes of trading here are some market features:   * Bonds are getting schmeissed. The 10-year U.S. note yield is close to…

Biotech Sees Sharp Reversal Real Money Pro($)

Biotech, as represented by iShares Nasdaq Biotechnology Index Fund (IBB) , universally beloved by technicians and "talking heads" has just suff…
"Keep the juices flowin' by janglin' round gently as you move." -- Jonathan Heller,  Catch The Wisdom   As of …
Case in point: Home Depot and Lowe's.
It's difficult for even the best companies to resist infection.

Some Lunchtime Reading Real Money Pro($)

As we head into the lunch hour, here's some reading that I think/hope you'll enjoy:

Columnist Conversations

View Chart »  View in New Window »
View Chart »  View in New Window »
we like this chart here, it appears ready to move higher. BOUGHT BZUN OCT 35 CALL AT 3.40
Large-cap, high-quality McKesson (MCK) is too cheap now, at $147.51 or so. The stock hit $243.60 more than 2.5...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.